OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAA0. A total of 1 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 3.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$1,817,000,0002,000,0000.03%
Other shareholders
INOTEK PHARMACEUTICALS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
Opaleye Management Inc. 642,800$6,042,0002.97%
View complete list of INOTEK PHARMACEUTICALS CORP shareholders